-
psnet.ahrq.gov/node/50370/psn-pdf
January 01, 2020 - A past WebM&M commentary described an
incident involving miscommunication in the operating room that
-
psnet.ahrq.gov/node/73130/psn-pdf
January 01, 2022 - Vineet Chopra described the development and implementation of MAGIC
in Michigan hospitals.
-
psnet.ahrq.gov/node/47900/psn-pdf
January 01, 2021 - survey, 85% of physicians reported involvement in either an adverse event or near miss, and nearly half
described
-
psnet.ahrq.gov/node/73214/psn-pdf
May 05, 2021 - Patients and primary care providers described their knowledge and awareness of risk of falls
related
-
psnet.ahrq.gov/sites/default/files/2024-10/spotlight_case_delayed_symptomatic_subdural_hematoma_slides.pptx
January 01, 2024 - among patients not taking (0.7%) versus those taking antithrombotics (0.6%).11
Mourad and colleagues described … subdural hematomas have been reported to occur after initially negative head CTs, as in the patient described … Olivero and colleagues described 37 patients who underwent surgery for chronic subdural hematomas, 7 … In a series described by Amrhein and colleagues,25 the sensitivity and specificity of a non-enhanced … difficulties with concentration and memory were attributed to the prior concussion (a cognitive bias sometimes described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-2_1.pdf
January 01, 2012 - The policies and procedures described here support the RoPR’s goals of providing
a searchable central … These are described in the next section. … As described
earlier, funding organizations, both public and private, might require registration as … Such negative
incentives are viewed as less likely to be enacted given the reasons described in the … Stakeholders recommended that the RoPR maintain the outreach and dissemination activities
described
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
November 16, 2010 - These types of glaucoma may also be described in the
literature as the following conditions:
• … The outcomes are as described above in Outcomes for Key Questions
1 through 4, and the criteria for … inclusion/exclusion are described in Section IV-A. … The specific populations, interventions, and outcomes of interest are described in Section II. … Studies labeled “ include” will be further assessed for methodological quality as
described in Section
-
psnet.ahrq.gov/node/46043/psn-pdf
April 05, 2017 - This magazine article described how a
13-hospital health system used handoff standardization tools such
-
psnet.ahrq.gov/node/45071/psn-pdf
April 27, 2016 - psnet.ahrq.gov/issue/using-simulation-identify-sources-medical-diagnostic-error-child-physical-abuse
This study described
-
psnet.ahrq.gov/node/45929/psn-pdf
August 23, 2017 - /issue/managing-diagnostic-uncertainty-primary-care-systematic-critical-review
A recent commentary described
-
psnet.ahrq.gov/node/33825/psn-pdf
January 01, 2017 - Indeed, one early study that
described the RCA process within the Veterans Affairs health system did … effectiveness-and-efficiency-root-cause-analysis-medicine
In a widely cited 2016 commentary, Peerally and colleagues described … Focusing more specifically on problems with RCA tools and techniques, Card described "the problem with … An earlier study
described the development and adoption of a rapid approach to RCAs, referred to as
-
hcup-us.ahrq.gov/datainnovations/clinicalcontentenhancementtoolkit/mn22.jsp
September 01, 2014 - Readmission
Process diagram showing 30 day readmission matches going through the four algorithms described … on page 13 and ending up in the three databases described on page 14. … Day Death
Process diagram showing 30 day death matches going through three of the four algorithms described … on page 13 (that is, not including algorithm 2) and ending up in the three databases described on page
-
psnet.ahrq.gov/node/49683/psn-pdf
April 01, 2013 - In addition, the GI consult
described how the patient requested a reduction in the haloperidol dose … Adverse motor
effects associated with this antagonism (e.g., Parkinsonism and dystonia) were described … At least one case report has described this pattern with olanzapine.(11) Withdrawal
dyskinesias, presumably … related to dopaminergic sensitivity, are also described.(12) Additional
discontinuation symptoms, related
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-204-obesity-disposition-comments.pdf
December 01, 2017 - The extent to
which this occurs should be assessed and described. … Reviewer #4: Clarity and
Usability
The limitations and future research are described. … We described how we operationalized the
definition to make it clearer. … Reviewer #1: Methods The PICOTS framework was well laid out and well described. … Many of these interventions were
described as multi-dimensional and had
multiple targets.
-
digital.ahrq.gov/ahrq-funded-projects/chronic-care-technology-project/annual-summary/2010
January 01, 2010 - Findings and lessons learned were described in the final report. … They are described below. … This project was intended to help organizations implement technology solutions to improve care as described
-
psnet.ahrq.gov/node/47043/psn-pdf
January 01, 2019 - association-nurse-engagement-and-nurse-staffing-patient-safety
This cross-sectional study found that nurses reporting a lower level of engagement also described
-
psnet.ahrq.gov/node/34805/psn-pdf
November 07, 2017 - The overall error rate reported per admission approached 15% with several classification
types described
-
psnet.ahrq.gov/node/43243/psn-pdf
June 11, 2014 - Physicians
described the process to be valuable, educational, and effective.
-
psnet.ahrq.gov/node/44017/psn-pdf
April 08, 2018 - Although the authors described some of the potential benefits of these apps, they
note that their research
-
psnet.ahrq.gov/node/44113/psn-pdf
November 06, 2015 - doctors at a British hospital reported a willingness to help improve safety by reporting concerns, but
described